JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 103 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,121 | -67.3% | 14,660 | -58.8% | 0.00% | – |
| Q3 2022 | $83,000 | +22.1% | 35,599 | +58.2% | 0.00% | – |
| Q2 2022 | $68,000 | -59.0% | 22,500 | -8.2% | 0.00% | -100.0% |
| Q1 2022 | $166,000 | -19.0% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $205,000 | +12.6% | 24,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $182,000 | +9.0% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $167,000 | -24.4% | 24,500 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $221,000 | +176.2% | 21,500 | +87.0% | 0.00% | +100.0% |
| Q4 2020 | $80,000 | -19.2% | 11,500 | +4.5% | 0.00% | -50.0% |
| Q3 2020 | $99,000 | +35.6% | 11,000 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $73,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,087,961 | $2,012,728 | 1.74% |
| Opaleye Management Inc. | 2,880,000 | $5,328,000 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 5,300,087 | $9,805,161 | 1.46% |
| Ardent Capital Management, Inc. | 923,463 | $1,708,407 | 1.23% |
| Beryl Capital Management LLC | 610,831 | $1,130,037 | 0.89% |
| Arena Investors LP | 610,639 | $1,129,682 | 0.88% |
| Omega Fund Management, LLC | 275,513 | $509,699 | 0.33% |
| Deep Track Capital, LP | 4,259,653 | $7,880,358 | 0.32% |
| PenderFund Capital Management Ltd. | 246,310 | $616 | 0.19% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 425,100 | $786,435 | 0.15% |